Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00186368 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Microarray Analysis of Gene Expression in Prostate Tissues

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Active, Not Recruiting to Completed Primary and study completion dates changed from estimate of Dec 2030 to Apr 21, 2009 · Collaborators: 2 to 3v18 Show all 3 changesShow less
    • Primary and study completion dates changed from estimate of Dec 2030 to Apr 21, 2009
    • Collaborators: 2 to 3

    See this version in full on ClinicalTrials.gov ↗

  2. Enrollment target: estimated 2000 to confirmed 867v17
  3. Re-verified, no change to tracked fieldsv16
  4. Primary and study completion dates: Dec 2021 to Dec 2030 Start date: Apr 1999 to Apr 6, 1999v15 Show all 2 changesShow less
    • Start date: Apr 1999 to Apr 6, 1999
  5. Collaborators expanded, about 9 wordsv14 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

Show 12 earlier versionsHide 12 earlier versions
  1. Re-verified, no change to tracked fieldsv13
  2. Primary and study completion dates: Dec 2017 to Dec 2021v12
  3. Study Status, Outcome Measuresv11
  4. Trial status: Recruiting to Active, Not Recruiting Site details revisedv10 Show all 2 changesShow less
    • Site details revised
  5. Re-verified, no change to tracked fieldsv9
  6. Enrollment target: 800 to 2000 Primary and study completion dates: Dec 2011 to Dec 2017v8 Show all 2 changesShow less
    • Primary and study completion dates: Dec 2011 to Dec 2017
  7. Primary and study completion dates: Dec 2011 Collaborators shortened, about 5 wordsv7 Show all 2 changesShow less
    • Collaborators shortened, about 5 words

    See this version in full on ClinicalTrials.gov ↗

  8. Re-verified, no change to tracked fieldsv6
  9. Eligibility criteria expanded, about 9 wordsv5 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

  10. 3 versions Re-verified since Mar 27, 2006, no change to tracked fieldsv2-v4
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to investigate gene expression profiles and biologic features of prostate tissue and how they relate to prostate cancer development and growth.
Trial Details
NCT Number NCT00186368
Lead Sponsor Stanford University
Collaborators: National Institutes of Health (NIH), University of Wisconsin, Madison, National Cancer Institute (NCI)
Conditions Prostate Cancer
Enrollment 867 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov